Provided by Tiger Trade Technology Pte. Ltd.

First Trust Nasdaq Pharmaceuticals ETF

42.00
-0.2593-0.61%
Post-market: 42.000.00000.00%16:10 EDT
Volume:325.77K
Turnover:13.70M
Market Cap:1.06B
PE:- -
High:42.13
Open:42.00
Low:41.83
Close:42.26
52wk High:42.87
52wk Low:27.30
Shares:25.15M
Float Shares:25.15M
Volume Ratio:3.47
T/O Rate:1.30%
Dividend:0.42
Dividend Rate:1.01%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Medtronic PLC Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
29 mins ago

Bristol-Myers Squibb Extends Deucravacitinib Program, Signaling Long-Term Autoimmune Ambitions

TIPRANKS
·
4 hours ago

Eli Lilly (LLY) Says Zepbound Cuts Healthcare Costs For Adults Over 55

Simply Wall St.
·
Yesterday

China's HBM Holdings H1 Revenue Rises on Progress on Mid-Late Clinical Stage Programs

Reuters
·
Yesterday

China's JW Therapeutics Interim Revenue Rises 4.7% on Carteyva Sales

Reuters
·
Yesterday

China Approves J&J's Oral Psoriasis Pill, Says Drugmaker

Reuters
·
Yesterday

Johnson & Johnson Says Oral Icotrokinra Approved in China for Moderate-to-Severe Plaque Psoriasis - Statement

THOMSON REUTERS
·
Yesterday

AbbVie Seeks EMA Approval for Skyrizi Subcutaneous Induction in Crohn’s Disease

Reuters
·
Yesterday

Abbvie Submits Regulatory Application to Ema for Skyrizi® (Risankizumab) Subcutaneous Induction for Adults with Moderately to Severely Active Crohn's Disease

THOMSON REUTERS
·
Yesterday

Top Bristol-Myers Squibb Executive Makes Notable Move With Recent Stock Sale

TIPRANKS
·
Yesterday

RBC Capital Reaffirms Their Hold Rating on Merck & Company (MRK)

TIPRANKS
·
Yesterday

Eli Lilly & Co. Stock Slips 3.6%, Underperforms Peers

Dow Jones
·
Yesterday

AbbVie Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Yesterday

Bristol Myers Squibb SVP, Controller Phil M. Holzer Sells 500 Shares for $33,750

Reuters
·
Yesterday

Sector Update: Healthcare

MT Newswires Live
·
Yesterday

US FDA - Issues Early Alert on Abiomed Heart Pump Controller Purge Cassette Issue

THOMSON REUTERS
·
Yesterday

Eli Lilly Expands Alzheimer’s Pipeline With New Amyloid Phase 1 Trial

TIPRANKS
·
Yesterday

Eli Lilly Stock (LLY) in Focus as Alzheimer’s Blood Test Gets FDA Approval

TIPRANKS
·
Aug 26

Nike, Merck Share Losses Contribute to Dow's 150-Point Drop

Dow Jones
·
Aug 26

Bloomsbury Ties Executive Share Awards to Long-Term Performance Targets

TIPRANKS
·
Aug 26